Should a test of cure be performed after completing a full‑dose 10‑14‑day Helicobacter pylori eradication regimen (triple, quadruple, or sequential therapy) in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Test of Cure After H. pylori Eradication: Mandatory Standard of Care

Yes, you must recheck H. pylori status after completing eradication therapy—confirmation of eradication is now considered the standard of care for all patients. 1

Why Test of Cure is Essential

Persistent H. pylori infection is a negative prognostic marker for ulcer recurrence, bleeding complications, and treatment failure in MALT lymphoma. 1, 2 The success of eradication directly determines whether ulcers will remain healed long-term, making confirmation testing critical rather than optional. 1

Additionally, confirming eradication provides an indirect measure of antibiotic resistance patterns in your patient population, which helps guide future treatment decisions. 1

Timing: When to Perform the Test

Wait at least 4 weeks after completing treatment before testing. 1, 3 Testing earlier than 4 weeks will yield false-negative results because the gastric mucosa needs time to recover from treatment effects, and you may detect temporary bacterial suppression rather than true eradication. 1, 3

Special timing considerations:

  • Bleeding peptic ulcers: Delay testing to 4-8 weeks after the bleeding episode 1, 3
  • Gastric MALT lymphoma: Wait at least 6 weeks after eradication therapy 3

Which Test to Use

Use either the urea breath test (UBT) or a validated monoclonal stool antigen test—both are equally accurate and interchangeable. 1

Test performance characteristics:

  • Urea breath test: Sensitivity 94.7-97%, specificity 95-100% 1, 3
  • Monoclonal stool antigen test: Sensitivity and specificity >90% 1, 3
  • Serology has NO role: Antibody levels remain elevated after eradication, making serology useless for confirming cure 1

The stool antigen test is particularly useful when patients must continue PPI therapy, as it may be less affected by acid suppression than the UBT. 3

Critical Pre-Test Preparation Requirements

Failure to properly prepare patients before testing is a common pitfall that leads to false-negative results. 1

Mandatory washout periods:

  • Stop antibiotics and bismuth: At least 4 weeks before testing 1, 3
  • Stop PPIs: At least 2 weeks (preferably 7-14 days) before testing 3
  • Fasting: At least 6 hours before the test 1, 3

The stool antigen test may allow continued PPI use with less interference, but stopping PPIs remains preferable when possible. 3

High-Risk Scenarios Requiring Endoscopic Follow-Up

While non-invasive testing suffices for most patients, certain clinical scenarios mandate endoscopy with biopsy-based testing: 1

  • Gastric ulcer patients: Require endoscopic follow-up to ensure complete ulcer healing AND confirm H. pylori eradication 1, 3
  • Gastric MALT lymphoma: Must undergo upper endoscopy with biopsy, as persistent infection predicts treatment failure 1, 3
  • Complicated peptic ulcer disease: Should have endoscopic confirmation when clinically indicated 1

What to Do After Testing

If eradication is confirmed:

  • Discontinue PPI therapy in uncomplicated duodenal ulcer cases 1
  • Continue PPI in gastric ulcer patients until complete healing is documented 1
  • Continue PPI in complicated duodenal ulcer or bleeding ulcer patients until eradication is confirmed 1
  • No further H. pylori testing is needed unless symptoms recur 1

If H. pylori persists:

  • Never repeat the same antibiotic regimen—this leads to further resistance and treatment failure 1
  • Use a completely different antibiotic combination, avoiding any antibiotics used in the first regimen 1
  • After two treatment failures, pursue antibiotic susceptibility testing to guide third-line therapy 1
  • Review prior antibiotic exposures: Avoid clarithromycin if the patient has received any macrolide, and avoid levofloxacin if they have received any fluoroquinolone 1

Common Pitfalls to Avoid

  • Testing too early (before 4 weeks): Yields unreliable false-negative results 1
  • Using serology for test of cure: Cannot distinguish active infection from past exposure 1
  • Inadequate medication washout: PPIs, antibiotics, or bismuth taken too close to testing will cause false negatives 1, 3
  • Assuming symptom resolution equals eradication: Only 38% of successfully treated patients report complete symptom resolution, meaning symptoms are an unreliable marker of cure 4
  • Repeating the same failed regimen: This guarantees treatment failure due to antibiotic resistance 1

References

Guideline

Test of Cure After H. pylori Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Side Effects During H. pylori Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Timing of Urea Breath Test After H. pylori Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is confirmatory testing for Helicobacter pylori (H. pylori) eradication indicated after treatment?
What is the recommended next step for a patient with resolved symptoms after antibiotic treatment for Helicobacter pylori (H. pylori) infection, with normal vitals and no underlying conditions?
When should Helicobacter pylori (H. pylori) infection be retested after treatment?
How soon can a test for Helicobacter pylori (H. pylori) eradication be repeated after completing eradication therapy?
How long after a gastrointestinal bleed can a fecal antigen test for Helicobacter pylori be performed?
What is the Palliative Performance Scale?
What is the most likely etiology and appropriate evaluation for a patient with low alkaline phosphatase, low blood urea nitrogen, and a serum chloride of 109 mmol/L?
In a 36-year-old with a 10-day intense cough, mild‑moderate sore throat and chest wall pain, who has been taking dextromethorphan 7.5 mg twice daily and amoxicillin‑clavulanate (Augmentin) 625 mg twice daily for 5 days with only 10‑20% cough improvement, what is the most likely diagnosis and appropriate management?
How should I describe a friction (abrasion) burn on physical examination?
How do I start oral minoxidil for a patient with androgenetic (genetic) alopecia or female‑pattern hair loss, including initial dose, baseline labs, contraindications, monitoring, and alternative options?
What is the appropriate management for an acute deep vein thrombosis in a previously healthy 30-year-old man?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.